2-Styrylchromone derivatives as potent and selective monoamine oxidase B inhibitors
- PMID: 31561103
- DOI: 10.1016/j.bioorg.2019.103285
2-Styrylchromone derivatives as potent and selective monoamine oxidase B inhibitors
Abstract
A series of eighteen 2-styrylchromone derivatives (see Chart 1) were synthesized and evaluated for their monoamine oxidase (MAO) A and B inhibitory activities. Many of the derivatives inhibited MAO-B comparable to pargyline (a positive control), and most of them inhibited MAO-B selectively. Of the eighteen derivatives, compound 9 having methoxy group at R1 and chlorine at R4 showed both the best MAO-B inhibitory activity (IC50 = 17 ± 2.4 nM) and the best MAO-B selectivity (IC50 for MAO-A/IC50 for MAO-B = 1500). The mode of inhibition of compound 9 against MAO-B was competitive and reversible. Quantitative structure-activity relationship (QSAR) analyses of the 2-styrylchromone derivatives were conducted using their pIC50 values with the use of Molecular Operating Environment (MOE) and Dragon, demonstrating that the descriptors of MAO-B inhibitory activity and MAO-B selectivity were 1734 and 121, respectively, that showed significant correlations (P < 0.05). We then examined the 2-styrylchromone structures as useful scaffolds through three-dimensional-QSAR studies using AutoGPA, which is based on the molecular field analysis algorithm using MOE. The model using pIC50 value indexes for MAO-B exhibited a determination coefficient (R2) of 0.873 as well as a Leave-One-Out cross-validated determination coefficient (Q2) of 0.675. These data suggested that the 2-styrylchromone structure might be a useful scaffold for the design and development of novel MAO-B inhibitors.
Keywords: 2-Styrylchromone; AutoGPA; Molecular Operating Environment; Monoamine oxidase-A; Monoamine oxidase-B; Quantitative structure–activity relationship.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Synthesis and biological evaluation of 3-styrylchromone derivatives as selective monoamine oxidase B inhibitors.Bioorg Med Chem. 2021 Jul 15;42:116255. doi: 10.1016/j.bmc.2021.116255. Epub 2021 Jun 5. Bioorg Med Chem. 2021. PMID: 34119696
-
3-(E)-Styryl-2H-chromene derivatives as potent and selective monoamine oxidase B inhibitors.Bioorg Chem. 2018 Apr;77:436-442. doi: 10.1016/j.bioorg.2018.01.036. Epub 2018 Feb 7. Bioorg Chem. 2018. PMID: 29448189
-
2-Azolylchromone Derivatives as Potent and Selective Inhibitors of Monoamine Oxidases A and B.Chem Pharm Bull (Tokyo). 2016;64(10):1499-1504. doi: 10.1248/cpb.c16-00527. Chem Pharm Bull (Tokyo). 2016. PMID: 27725503
-
Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review.Comb Chem High Throughput Screen. 2017;20(6):522-532. doi: 10.2174/1386207320666170227155517. Comb Chem High Throughput Screen. 2017. PMID: 28245770 Review.
-
Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors.Curr Med Chem. 2006;13(12):1411-28. doi: 10.2174/092986706776872907. Curr Med Chem. 2006. PMID: 16719786 Review.
Cited by
-
Styrylchromones: Biological Activities and Structure-Activity Relationship.Oxid Med Cell Longev. 2021 Dec 22;2021:2804521. doi: 10.1155/2021/2804521. eCollection 2021. Oxid Med Cell Longev. 2021. Retraction in: Oxid Med Cell Longev. 2024 Jan 9;2024:9810761. doi: 10.1155/2024/9810761. PMID: 34987699 Free PMC article. Retracted. Review.
-
Synthesis and multi-target evaluation of 2-(2-phenylethyl)/2,3-styrylchromone derivatives as potential anti-Alzheimer's disease agents.Mol Divers. 2025 Jul 13. doi: 10.1007/s11030-025-11284-6. Online ahead of print. Mol Divers. 2025. PMID: 40652414
-
Activity Models of Key GPCR Families in the Central Nervous System: A Tool for Many Purposes.J Chem Inf Model. 2023 Jun 12;63(11):3248-3262. doi: 10.1021/acs.jcim.2c01531. Epub 2023 May 31. J Chem Inf Model. 2023. PMID: 37257045 Free PMC article.
-
Development of Newly Synthesized Chromone Derivatives with High Tumor Specificity against Human Oral Squamous Cell Carcinoma.Medicines (Basel). 2020 Aug 26;7(9):50. doi: 10.3390/medicines7090050. Medicines (Basel). 2020. PMID: 32858984 Free PMC article. Review.
-
Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics.RSC Med Chem. 2022 Jan 31;13(3):258-279. doi: 10.1039/d1md00394a. eCollection 2022 Mar 23. RSC Med Chem. 2022. PMID: 35434628 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources